Waverley Pharma Inc. (TSXV:WAVE)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Jun 2, 2026, 4:00 PM EST
Waverley Pharma Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.25 | 1.35 | 0.48 | 0.41 | 1.25 | 1.75 | |
Revenue Growth (YoY) | 43.69% | 183.90% | 15.36% | -66.95% | -28.87% | 27.47% |
Cost of Revenue | 0.78 | 0.84 | 0.26 | 0.33 | 0.96 | 1.53 |
Gross Profit | 0.46 | 0.51 | 0.21 | 0.08 | 0.28 | 0.22 |
Selling, General & Admin | 0.9 | 0.85 | 0.65 | 1.13 | 1.14 | 0.98 |
Research & Development | 0.01 | 0.01 | 0.42 | 0.23 | 0.08 | 0.03 |
Total Operating Expenses | 0.92 | 0.86 | 1.08 | 1.36 | 1.22 | 1.01 |
Operating Income | -0.45 | -0.35 | -0.86 | -1.28 | -0.94 | -0.79 |
Interest Income | 0.17 | 0.15 | 0.2 | 0.08 | 0.03 | 0.05 |
Other Non-Operating Income (Expense) | - | - | 0.12 | -0.86 | 0.3 | 0.04 |
Total Non-Operating Income (Expense) | 0.17 | 0.15 | 0.32 | -0.79 | 0.32 | 0.09 |
Pretax Income | -0.28 | -0.2 | -0.54 | -2.07 | -0.61 | -0.69 |
Provision for Income Taxes | 0 | 0 | - | - | - | - |
Net Income | -0.63 | -0.5 | -0.95 | -2.22 | -0.66 | -0.8 |
Net Income to Common | -0.63 | -0.5 | -0.95 | -2.22 | -0.66 | -0.8 |
Shares Outstanding (Basic) | 54 | 54 | 54 | 54 | 54 | 54 |
Shares Outstanding (Diluted) | 54 | 54 | 54 | 54 | 54 | 54 |
EPS (Basic) | - | -0.01 | -0.02 | -0.04 | -0.01 | -0.01 |
EPS (Diluted) | - | -0.01 | -0.02 | -0.04 | -0.01 | -0.01 |
Shares Outstanding | 54 | 54 | 54 | 54 | 54 | 54 |
Free Cash Flow | -0.51 | -0.61 | -0.41 | -1.02 | -0.24 | -0.8 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.02 | -0.00 | -0.01 |
Gross Margin | 37.34% | 38.06% | 45.03% | 19.36% | 22.76% | 12.70% |
Operating Margin | -36.34% | -25.88% | -181.32% | -311.30% | -75.08% | -44.89% |
Profit Margin | -22.47% | -15.02% | -113.61% | -502.22% | -49.10% | -39.55% |
FCF Margin | -41.32% | -45.28% | -86.29% | -247.79% | -19.01% | -45.57% |
EBITDA | -0.27 | -0.16 | -0.73 | -0.86 | -0.72 | -0.72 |
EBITDA Margin | -21.35% | -11.98% | -154.31% | -207.86% | -58.07% | -40.88% |
EBIT | -0.45 | -0.35 | -0.86 | -1.28 | -0.94 | -0.79 |
EBIT Margin | -36.34% | -25.88% | -181.32% | -311.30% | -75.08% | -44.89% |
Effective Tax Rate | -0.59% | -0.81% | 0.00% | 0.00% | 0.00% | 0.00% |